Page last updated: 2024-12-09
methyl maslinate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
methyl maslinate: isolated from the radix of Vaccinium scopulorum [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Vaccinium | genus | A plant genus of the family ERICACEAE known for species with edible fruits.[MeSH] | Ericaceae | The heath plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida that are generally shrubs or small trees. Leaves are alternate, simple, and leathery; flowers are symmetrical with a 4- or 5-parted corolla of partly fused petals.[MeSH] |
| Vaccinium scopulorum | species | [no description available] | Ericaceae | The heath plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida that are generally shrubs or small trees. Leaves are alternate, simple, and leathery; flowers are symmetrical with a 4- or 5-parted corolla of partly fused petals.[MeSH] |
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 609113 |
| MeSH ID | M0209128 |
Synonyms (7)
| Synonym |
|---|
| methyl maslinate |
| maslinic acid methyl ester |
| methyl 2,3-dihydroxyolean-12-en-28-oate # |
| olean-12-en-28-oic acid, 2,3-dihydroxy-, methyl ester, (2.alpha.,3.alpha.)- |
| OTDUGESKRJHFHR-UHFFFAOYSA-N |
| olean-12-en-28-oic acid, 2.alpha.,3.alpha.-dihydroxy-, methyl ester |
| methyl 3-epimaslinate |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " They displayed significant, dose-response vasodepressor effect and sinus bradicardia, most prominent for OA and MM." | ( Cardiotonic and antidysrhythmic effects of oleanolic and ursolic acids, methyl maslinate and uvaol. Mipando, M; Shode, FO; Somova, LI, 2004) | 0.56 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.82
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.82) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||